Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent Complaints After COVID-19: Epidemiology, Pathophysiology, Prediction, and Communication, the CORona Follow Up (CORFU) Study

NCT05240742 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT05240742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent Complaints After COVID-19: Epidemiology, Pathophysiology, Prediction, and Communication, the CORona Follow Up (CORFU) Study
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
October 1, 2021
Completion date
November 1, 2024
Enrollment
4,291 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, long covid, post covid-19 condition